Printer Friendly

Browse Fibrosis topic

Genetic aspects subtopic

Articles

1-39 out of 39 article(s)
Title Author Type Date Words
Perilipin 2 Protects against Lipotoxicity-Induced Islet Fibrosis by Inducing Islet Stellate Cell Activation Phenotype Changes. Zhou, Yunting; Wang, Yuming; Ni, Chengming; Wang, Huiying; Zhou, Junming; Wan, Bingying; Li, Huiqin Report Jul 6, 2022 5862
Association of Equiliberative Nucleoside Transporter (ENT) with liver fibrosis stage in Hepatitis-C. Jun 16, 2022 2668
Single Nucleotide Polymorphisms of IL-33 Gene Correlated with Renal Allograft Fibrosis in Kidney Transplant Recipients. Liu, Xuzhong; Liu, Kun; Gui, Zeping; Feng, Dengyuan; Wang, Zijie; Zheng, Ming; Fei, Shuang Dec 13, 2021 7876
Differential Gender-Dependent Patterns of Cardiac Fibrosis and Fibroblast Phenotypes in Aging Mice. Achkar, Angela; Saliba, Youakim; Fares, Nassim Jun 30, 2020 5866
Congenital Hepatic Fibrosis in Children and Adults: Clinical Manifestations, Management, and Outcome--Case Series and Literature Review. Zhu, Beidi; Du, Zunguo; Wang, Zhengxin; Li, Yang; Zhang, Jiming; Zhu, Haoxiang May 31, 2020 6145
Cystic Fibrosis Liver Disease: Know More. Sinani, Siham Al; Mulaabed, Sharef Al-; Naamani, Khalid Al; Sultan, Rabab Nov 1, 2019 5090
FDA approves new first triple combination therapy Trikafta (elexacaftor/ivacaftor/tezacaftor) for cystic fibrosis. Oct 22, 2019 337
FDA approves new first triple combination therapy Trikafta (elexacaftor/ivacaftor/tezacaftor) for cystic fibrosis. Oct 22, 2019 333
A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes. Kurtoglu, Elcin Latife; Kayhan, Basak; Gul, Mehmet; Kayhan, Burcak; Kayhan, Meral Akdogan; Karaca, Z Aug 1, 2019 6092
A bioactive product iipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes. Kurtoglu, Elgin Latife; Kayhan, Bagak; Gul, Mehmet; Kayhan, Burgak; Kayhan, Meral Akdogan; Karaca, Z Aug 1, 2019 6855
US FDA expands use of Symdeko to include patients ages six years and older for cystic fibrosis. Jun 24, 2019 326
US FDA expands use of Symdeko to include patients ages six years and older for cystic fibrosis. Jun 24, 2019 330
Triple Combo Regimens May Address Cause of Cystic Fibrosis; Promising results for VX-659-, VX-445-tezacaftor-ivacaftor for cystic fibrosis with mutations in CFTR. Oct 19, 2018 319
KIF21A Gene c.2860C>T Mutation in CFEOMlA: The First Report from Iran. Ramahi, Masoomeh; Rad, Abolfazl; Shirzadeh, Ebrahim; Najafi, Maryam Case study Oct 1, 2018 2003
TGFB1 Mutation Ups Radiation-Induced Breast Fibrosis Risk; C-509T allele and postoperative cosmetic surgery significantly linked to breast fibrosis risk. Clinical report Aug 2, 2018 265
Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease. Shi, Juan; Li, Hui; Yuan, Chao; Luo, Meihui; Wei, Jun; Liu, Xiaoming Jan 1, 2018 9773
MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy. Zhang, Yingying; Zhao, Siqi; Wu, Depei; Liu, Xingmei; Shi, Mingjun; Wang, Yuanyuan; Zhang, Fan; Ding Jan 1, 2018 5208
Atypical Chemokine Receptor 1 polymorphism cannot be used as an indicator of liver fibrosis progression in Hepatitis C virus positive patients. Report Oct 31, 2017 2320
The US FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis to 33. May 18, 2017 286
The US FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis to 33. May 18, 2017 282
TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes. Ryu, Jihye; Lee, Jung Weon Report Jan 1, 2017 3651
Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients. Bhat, Mamatha; Rollet-Kurhajec, Kathleen C.; Bhat, Aparna; Farag, Amanda; Deschenes, Marc; Wong, Phi Report Jan 1, 2017 5636
Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients. Parra, Micaela; Laufer, Natalia; Manrique, Julieta M.; Jones, Leandro R.; Quarleri, Jorge Report Jan 1, 2017 7089
miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway. Ma, Tengfei; Cai, Xiuqin; Wang, Zifeng; Huang, Li; Wang, Chang; Jiang, Songshan; Hua, Yunpeng; Liu, Report Jan 1, 2017 4545
TONGUE FLAP IN ORAL SUBMUCOUS FIBROSIS: A PROMISING TECHNIQUE. Case study Dec 31, 2016 1747
Kruppel-like factor 4 inhibits the transforming growth factor-[beta]1-promoted epithelial-to-mesenchymal transition via downregulating plasminogen activator inhibitor-1 in lung epithelial cells. Sun, Fang; Hu, Ke Report Jan 1, 2016 4813
Congenital fibrosis of the extraocular muscles/Konjenital ekstraokuler kas fibrozisi. Niyaz, Leyla; Can, Ertugrul Report Jul 1, 2014 2379
Serum inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) in children with chronic hepatitis C: relation to liver fibrosis and viremia. Sira, Mostafa M.; Behairy, Behairy E.; Abd-Elaziz, Azza M.; Elnaby, Sameh A. Abd; Eltahan, Ehab E. Report Jan 1, 2014 4982
TRPV1 activation attenuates high-salt diet-induced cardiac hypertrophy and fibrosis through PPAR-[delta] upregulation. Gao, Feng; Liang, Yi; Wang, Xiang; Lu, Zongshi; Li, Li; Zhu, Shanjun; Liu, Daoyan; Yan, Zhencheng; Z Report Jan 1, 2014 5195
Activation of hepatic stellate cells by the aryl hydrocarbon receptor during experimental liver fibrosis. Lamb, Cheri L.; Mitchell, Kristen A. Author abstract Jun 1, 2013 219
IL-10 treatment is associated with prohibitin expression in the Crohn's disease intestinal fibrosis mouse model. Yuan, C.; Chen, W.-X.; Zhu, J.-S.; Chen, N.-W.; Lu, Y.-M.; Ou, Y.-X.; Chen, H.- Q. Report Jan 1, 2013 4983
The possible potential therapeutic targets for drug induced gingival overgrowth. Subramani, Tamilselvan; Rathnavelu, Vidhya; Alitheen, Noorjahan Banu Report Jan 1, 2013 6905
Combined effects of PPAR[gamma] agonists and epidermal growth factor receptor inhibitors in human proximal tubule cells. Pegg, Katherine; Zhang, Jie; Pollock, Carol; Saad, Sonia Report Jan 1, 2013 4417
The association between JAK2V617F mutation and bone marrow fibrosis at diagnosis in patients with philadelphia-negative chronic myeloproliferative neoplasms / Philadelphia Negatif kronik Miyeloproliferatif Neoplazili Hastalarin Tanisinda JAK2V617F mutasyonu ile Kemik Iligindeki Fibrozun Iliskisi. Cem Ar, M; Buyuktas, Deram; Eskazan, A. Emre; Aydin, Seniz Ongoren; Tanrikulu, Eda; Baslar, Zafer; B Report Sep 1, 2012 3175
Proteostasis Therapeutics forms research partnership with Cystic Fibrosis Foundation Therapeutics. May 7, 2012 153
Abbott donates USD18,000 to Jason Egbert in aid of cystic fibrosis. Nov 12, 2010 164
Looking for a cure for Luka; GENETIC: Charity fund-raiser for research into cystic fibrosis. Mar 27, 2009 275
Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Nasis, Ourania; Thompson, Shanel; Hong, Tom; Sherwood, Margaret; Radcliffe, Shawn; Jackson, Laird; O Apr 1, 2004 5717
Cystic fibrosis syndrome: a new paradigm for inherited disorders and implications for molecular diagnostics. Friedman, Kenneth J.; Silverman, Lawrence M. Jul 1, 1999 2647

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |